VisionGuard AI
Portable AI-Powered Retinal Screening for Everyone
AI-driven retinal imaging that detects diabetic retinopathy, glaucoma, and age-related macular degeneration in under 60 seconds.
Problem
Over 75% of vision loss in Africa is preventable, yet specialist ophthalmic care is concentrated in urban centers, leaving millions undiagnosed until it's too late.
Solution
A smartphone-attachable retinal camera paired with a clinically-trained AI model that delivers screening-grade reports anywhere a community health worker can travel.
Market Opportunity
Sub-Saharan Africa has more than 26 million people living with diabetes and a fast-growing aging population — a multi-billion dollar preventative-care opportunity.
Target Customers
Primary health centers, NGOs running outreach programs, optometry chains, diabetes clinics, and insurance providers.
Business Model
Device leasing + per-scan SaaS pricing for clinics, bulk licensing for governments and NGOs.
Progress
Working prototype, clinical validation partnerships in design, dataset curation in progress.
Growth Potential
Pathway to expand into cardiovascular and neurological screening from the same imaging substrate.
Funding Opportunity
Seeking seed capital to complete clinical validation and CE-mark equivalent regulatory submission.
Investor HubPartnership Opportunity
Ophthalmology departments, public-health agencies, telco partners for last-mile distribution.
Explore PartnershipsInterested in VisionGuard AI?
Get in touch to discuss investment, partnership, or pilot opportunities.
Contact the Lab